g.valckenaere
TL3 Regular · Lausanne, CH
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 4 January 2025 · last posted 3d · groups: pharmacists
125 posts, newest first. Showing up to 150.
-
Coming back to: Time to steady state after a dose increase Replied, post #110 · Pharmacology › Pharmacokinetics · 25 Jul 2026 · 24 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #61 · Analytics › HPLC & UHPLC · 23 Jul 2026 · 12 likes I read post #59 twice before replying, because I had assumed the opposite. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #77 · Compounds › Retatrutide · 20 Jul 2026 · 23 likes Worth separating two things that post #73 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Spreadsheets: an appreciation — what changed since Replied, post #106 · Lounge › Off topic · 20 Jul 2026 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #60 · Compounds › Repair & healing peptides · 15 Jul 2026 · 33 likes This follows post #57 rather than contradicting it. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by…
-
Pooling trials with different estimands Replied, post #93 · Evidence › Meta-analyses · 13 Jul 2026 · 15 likes I read post #91 twice before replying, because I had assumed the opposite. Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #13 · Access › Insurance & coverage · 9 Jul 2026 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
Restarting after a long gap: what the labelling implies Replied, post #14 · Practice › Dosing & titration · 6 Jul 2026 · 17 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Reused chromatograms across lots: how to spot it Replied, post #55 · Analytics › COA interpretation · 6 Jul 2026 · 0 likes On post #51 — agreed on the reasoning, with one qualification. When a document puts the specification in the result column, it has told you the release criterion, not…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #30 · Practice › Side effects · 4 Jul 2026 · 1 like Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #11 · Practice › Interactions · 4 Jul 2026 · 9 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Asking a follow-up: new topic or new reply? Replied, post #30 · Start Here › How to Ask · 29 Jun 2026 · 0 likes Coming back to post #28, because the follow-up matters more than the original answer. Disagreeing with an answer you got: cite what you disagree with, say what…
-
Personal or family history of medullary thyroid carcinoma Replied, post #27 · Safety › Contraindications · 29 Jun 2026 · 2 likes I read post #25 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
About the Shortages category Replied, post #4 · Access › Shortages · 23 Jun 2026 · 27 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Personal or family history of medullary thyroid carcinoma Replied, post #8 · Safety › Contraindications · 23 Jun 2026 · 0 likes This follows post #5 rather than contradicting it. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #27 · Access › International · 21 Jun 2026 · 13 likes Coming back to post #25, because the follow-up matters more than the original answer. Travel with medication: carrying a compound across borders is complicated by legal…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #13 · Pharmacology › Receptor biology · 8 Jun 2026 · 4 likes post #12 is right about the mechanism and I think understates the practical bit. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #92 · Practice › Reconstitution · 6 Jun 2026 · 7 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #14 · Pharmacology › Pharmacokinetics · 31 May 2026 · 0 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #71 · Practice › Reconstitution · 25 May 2026 · 16 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #17 · Sourcing › Independent verification · 23 May 2026 · 1 like Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #15 · Practice › Administration · 21 May 2026 · 0 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #6 · Research Methods › Statistics · 20 May 2026 · 27 likes Coming back to post #4, because the follow-up matters more than the original answer. Effect sizes: the magnitude of a difference, not just whether it is statistically…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #6 · Evidence › Meta-analyses · 14 May 2026 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
The anatomy of a question that gets answered within an hour Replied, post #41 · Start Here › How to Ask · 10 May 2026 · 0 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
A checklist for reading a certificate in under two minutes Replied, post #16 · Analytics › COA interpretation · 6 May 2026 · 16 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #25 · Compounds › Tirzepatide · 6 May 2026 · 5 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #81 · Evidence › Trials · 22 Apr 2026 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Follow-up: State-level differences that actually matter Replied, post #97 · Regional › North America · 9 Apr 2026 · 0 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
The "under review" status pill and when a moderator applies it Replied, post #58 · Evidence › Preprints · 6 Apr 2026 · 3 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #41 · Analytics › Mass spectrometry · 30 Mar 2026 · 4 likes This follows post #38 rather than contradicting it. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #8 · Analytics › Mass spectrometry · 14 Mar 2026 · 14 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #55 · Practice › Side effects · 11 Mar 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #128 · Practice › Interactions · 9 Mar 2026 · 29 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Constipation management, with a dietitian's contribution Replied, post #37 · Practice › Side effects · 6 Mar 2026 · 14 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Cost per delivered dose, which is the number that matters Replied, post #49 · Access › Pricing · 17 Feb 2026 · 0 likes On post #45 — agreed on the reasoning, with one qualification. Cost per milligram is the only comparison that survives format differences, but even then it needs care.…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Started this topic · Practice › Interactions · 16 Feb 2026 · 1 like A widely repeated interaction claim that turns out to be unsupported — what changed since Writing it up because I had to work it out twice and would rather nobody else…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #25 · Practice › Dosing & titration · 16 Feb 2026 · 17 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #133 · Analytics › COA interpretation · 16 Feb 2026 · 0 likes Coming back to post #131, because the follow-up matters more than the original answer. Reading old certificates: if a certificate is dated years ago, the lot it…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #90 · Documentation › Wiki requests · 15 Feb 2026 · 0 likes Picking up post #87: that is the part I would want checked first. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #46 · Evidence › Study critique · 12 Feb 2026 · 0 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
[2026 update] What a purity-only report leaves out Replied, post #21 · Sourcing › Independent verification · 10 Feb 2026 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #66 · Access › Pricing · 19 Jan 2026 · 0 likes post #65 is right about the mechanism and I think understates the practical bit. Compute cost per delivered dose at your dose if you want a number you can act on. That…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #13 · Research Methods › Statistics · 15 Jan 2026 · 0 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #20 · Practice › Side effects · 14 Jan 2026 · 2 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Alcohol: what is documented and what is folklore — the long version Replied, post #11 · Practice › Interactions · 12 Jan 2026 · 14 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #73 · Clinical › Special populations · 11 Jan 2026 · 0 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #5 · Access › International · 26 Dec 2025 · 18 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Heterogeneity as information rather than as a nuisance Replied, post #32 · Evidence › Meta-analyses · 20 Dec 2025 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Angle of injection and whether 90 degrees is always right Replied, post #67 · Practice › Administration · 17 Dec 2025 · 31 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #23 · Safety › Contraindications · 11 Dec 2025 · 0 likes On post #19 — agreed on the reasoning, with one qualification. Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #34 · Analytics › Method validation · 11 Dec 2025 · 1 like On post #30 — agreed on the reasoning, with one qualification. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately…
-
Tracking a preprint to publication: a worked example Replied, post #52 · Evidence › Preprints · 5 Dec 2025 · 17 likes On post #48 — agreed on the reasoning, with one qualification. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #53 · Compounds › Oral incretins · 20 Nov 2025 · 0 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Pen dose counters: what a click does and does not guarantee Replied, post #106 · Devices › Pens & autoinjectors · 19 Nov 2025 · 0 likes Picking up post #103: that is the part I would want checked first. Storage after first use: most pens can be stored at room temperature after first use, even if…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #19 · Sourcing › Regulatory · 19 Nov 2025 · 0 likes Picking up post #16: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Constipation management, with a dietitian's contribution Replied, post #3 · Practice › Side effects · 17 Nov 2025 · 29 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: The mass-error checker and its intended scope Replied, post #56 · Data & Tools › Calculators · 5 Nov 2025 · 26 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #76 · Practice › Reconstitution · 2 Nov 2025 · 7 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #42 · Start Here › How to Ask · 30 Oct 2025 · 11 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Sleep tracking data and its considerable limitations Replied, post #115 · Wellbeing › Sleep · 28 Oct 2025 · 14 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Sleep quality changes during weight loss — what changed since Replied, post #30 · Wellbeing › Sleep · 17 Oct 2025 · 0 likes post #29 answers the question as asked. The question underneath it is different. Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed)…
-
Thyroid function tests during substantial weight change Replied, post #81 · Clinical › Bloodwork · 2 Oct 2025 · 13 likes post #80 answers the question as asked. The question underneath it is different. A single value outside interval: usually uninformative on a single draw. What makes a…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #13 · Analytics › HPLC & UHPLC · 27 Sep 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What pooling buys you and what it destroys Replied, post #27 · Evidence › Meta-analyses · 23 Sep 2025 · 1 like Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Payment method and the leverage it gives you, ranked Replied, post #49 · Sourcing › Payments · 21 Sep 2025 · 24 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #132 · Data & Tools › Datasets · 11 Sep 2025 · 14 likes This follows post #129 rather than contradicting it. Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #46 · Practice › Administration · 4 Sep 2025 · 17 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #18 · Analytics › Method validation · 27 Aug 2025 · 18 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
A ten-fold dose error caught before injection Replied, post #84 · Devices › Syringes & needles · 18 Aug 2025 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #16 · Analytics › Method validation · 1 Aug 2025 · 0 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Mood changes: monitoring, and when to involve a professional Replied, post #3 · Wellbeing › Mental health · 1 Jul 2025 · 6 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #61 · Compounds › Cagrilintide & amylin analogues · 27 Jun 2025 · 2 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Repeatability versus intermediate precision Replied, post #65 · Analytics › Method validation · 26 Jun 2025 · 4 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Repeatability versus intermediate precision Replied, post #14 · Analytics › Method validation · 18 Jun 2025 · 31 likes On post #10 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #4 · Start Here › Welcome · 18 Jun 2025 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Sodium, potassium and magnesium when intake drops Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 16 Jun 2025 · 0 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Revisiting: German, French and Dutch differences, compared Replied, post #33 · Regional › European Union · 14 Jun 2025 · 0 likes I read post #31 twice before replying, because I had assumed the opposite. EMA is the regulator with national implementation. Licensed incretin analogues are…
-
Second pass at: Sleep tracking data and its considerable limitations Started this topic · Wellbeing › Sleep · 12 Jun 2025 · 10 likes Posting this under the heading it deserves: Second pass at: Sleep tracking data and its considerable limitations Everything below is what sits behind that. Asking about…
-
What this community means by "a source", in practical terms Replied, post #3 · Start Here › Welcome · 9 Jun 2025 · 17 likes post #2 answers the question as asked. The question underneath it is different. Marked solutions are the site's way of saying that someone asked a good question and…
-
A report I filed that turned out to be wrong, and the correction Replied, post #78 · Sourcing › Vendor reports · 30 May 2025 · 4 likes On post #74 — agreed on the reasoning, with one qualification. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from…
-
Lean mass preservation: what the evidence supports Replied, post #28 · Outcomes › Body composition · 22 May 2025 · 0 likes Picking up post #25: that is the part I would want checked first. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results…
-
A claim built entirely on a subgroup analysis Replied, post #46 · Evidence › Study critique · 21 May 2025 · 5 likes This follows post #43 rather than contradicting it. When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #154 · Sourcing › Regulatory · 17 May 2025 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #86 · Sourcing › Independent verification · 13 May 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
State-level differences that actually matter Replied, post #4 · Regional › North America · 5 May 2025 · 27 likes Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.
-
Dizziness on standing: the ordinary explanation first Replied, post #20 · Nutrition & Training › Hydration & electrolytes · 28 Apr 2025 · 20 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #29 · Data & Tools › Calculators · 23 Apr 2025 · 12 likes Picking up post #26: that is the part I would want checked first. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #36 · Compounds › Other compounds · 28 Mar 2025 · 0 likes I read post #34 twice before replying, because I had assumed the opposite. Compounds this community declines to help with, and why: there are specifics in the…
-
Sequence verification for an obscure compound: how it is done Replied, post #2 · Compounds › Other compounds · 27 Mar 2025 · 0 likes the opening post is right about the mechanism and I think understates the practical bit. When "no data" is the complete and final answer: if there is no published human…
-
When "no data" is the complete and final answer Replied, post #128 · Compounds › Other compounds · 25 Mar 2025 · 26 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #10 · Practice › Storage & stability · 24 Mar 2025 · 2 likes This follows post #7 rather than contradicting it. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #13 · Practice › Administration · 22 Mar 2025 · 16 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Validating a method you did not develop — does this still hold? Replied, post #145 · Analytics › Method validation · 21 Mar 2025 · 2 likes post #144 is right about the mechanism and I think understates the practical bit. Linearity: the detector response is proportional to compound concentration across the…
-
Retatrutide dose escalation in the published trials Replied, post #32 · Compounds › Retatrutide · 20 Mar 2025 · 28 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Charge states for a 4 kDa peptide, worked through Replied, post #76 · Analytics › Mass spectrometry · 11 Mar 2025 · 0 likes Picking up post #73: that is the part I would want checked first. Purity and identity are different questions: LC-MS establishes that the species at a retention time…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #77 · Pharmacology › Receptor biology · 11 Mar 2025 · 5 likes I read post #75 twice before replying, because I had assumed the opposite. Long-term receptor changes: very little is known about what happens to receptor expression,…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #93 · Compounds › Semaglutide · 9 Mar 2025 · 13 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Consistent declarations and why they matter more than clever ones Replied, post #150 · Sourcing › Logistics · 8 Mar 2025 · 24 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #4 · Devices › Syringes & needles · 4 Mar 2025 · 3 likes the opening post answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather…
-
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #5 · Analytics › Impurities & related substances · 15 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Consistent declarations and why they matter more than clever ones Replied, post #25 · Sourcing › Logistics · 12 Feb 2025 · 13 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
What a seizure notice actually says Replied, post #29 · Sourcing › Logistics · 31 Jan 2025 · 2 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #19 · Practice › Reconstitution · 24 Jan 2025 · 4 likes On post #15 — agreed on the reasoning, with one qualification. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #71 · Compounds › Semaglutide · 2 Jan 2025 · 28 likes Worth separating two things that post #67 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #65 · Compounds › Oral incretins · 27 Dec 2024 · 26 likes I read post #63 twice before replying, because I had assumed the opposite. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2…
-
Oxidation pathways for methionine and tryptophan Started this topic · Analytics › Impurities & related substances · 24 Dec 2024 · 24 likes Posting this under the heading it deserves: Oxidation pathways for methionine and tryptophan Everything below is what sits behind that. Working through the identity…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #35 · Compounds › Semaglutide · 24 Dec 2024 · 2 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Coming back to: When to suspect the method rather than the sample Replied, post #93 · Analytics › Method validation · 18 Dec 2024 · 6 likes Picking up post #90: that is the part I would want checked first. Linearity: the detector response is proportional to compound concentration across the working range.…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #23 · Devices › Cold chain · 17 Dec 2024 · 30 likes Worth separating two things that post #19 runs together. Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room…
-
Coming back to: When to suspect the method rather than the sample Replied, post #78 · Analytics › Method validation · 15 Dec 2024 · 0 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Body image changing more slowly than the body Replied, post #30 · Wellbeing › Mental health · 14 Dec 2024 · 0 likes This follows post #27 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
EMA product information as a primary source — does this still hold? Replied, post #144 · Regional › European Union · 19 Nov 2024 · 15 likes On post #140 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Merging two pages that cover the same ground — the long version Replied, post #10 · Documentation › Wiki requests · 17 Nov 2024 · 0 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
US compounding rules and how they changed Replied, post #40 · Regional › North America · 25 Oct 2024 · 0 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
Blind submission and why it changes minds Replied, post #79 · Sourcing › Independent verification · 5 Oct 2024 · 26 likes post #78 answers the question as asked. The question underneath it is different. Medutest: combined purity and identity reporting. Appears throughout vendor…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #105 · Sourcing › Independent verification · 3 Oct 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
When a red flag was a misunderstanding, and the retraction Replied, post #23 · Sourcing › Red flags · 26 Sep 2024 · 5 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #38 · Practice › Administration · 18 Sep 2024 · 11 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Promotion criteria, and the one that stops most nominations Replied, post #57 · Documentation › Doc review · 9 Sep 2024 · 8 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #34 · Evidence › Journal club · 4 Sep 2024 · 10 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #21 · Compounds › Semaglutide · 25 Aug 2024 · 24 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Cold packs, phase-change material, and what survives ten days Replied, post #135 · Sourcing › Logistics · 23 Jul 2024 · 0 likes I read post #133 twice before replying, because I had assumed the opposite. Insurance and carrier liability: most parcel carriers limit liability. Understanding the…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #94 · Practice › Dosing & titration · 9 Jul 2024 · 10 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
How this community labels and discusses unrefereed work Replied, post #60 · Evidence › Preprints · 4 Jul 2024 · 13 likes Picking up post #57: that is the part I would want checked first. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not…